Badenhoop K, Walfish P G, Rau H, Fischer S, Nicolay A, Bogner U, Schleusener H, Usadel K H
Medical Clinic, Klinikum of the Johann Wolfgang Goethe-University, Frankfurt/Main, Germany.
J Clin Endocrinol Metab. 1995 Jul;80(7):2112-7. doi: 10.1210/jcem.80.7.7608264.
Because particular human leukocyte antigen (HLA) DQ alleles are the major predisposing factors for type 1 diabetes mellitus (IDDM), we investigated whether they are shared by other endocrine autoimmune diseases. We, therefore, analyzed the HLA DQ genotypes of 171 patients with IDDM, 271 with Graves' disease (GD), 65 with Hashimoto's thyroiditis, 51 with postpartum thyroiditis, 53 with Addison's disease (AD), and 271 healthy controls. HLA DQA1 and DQB1 alleles were defined by polymerase chain reaction and sequence-specific oligonucleotide hybridization as well as by single strand conformational polymorphism analysis. HLA DQA10501 was significantly more frequent in IDDM (60%), GD (65%), and AD (70%) than in controls (43%); DQA10301 was significantly more frequent only in IDDM (67% vs. 30% controls). The heterozygous state DQA10301/0501 was found in 9% of controls and 35% of IDDM (relative risk, 5.6). An arginine at position 52 on either DQA1 allele was significantly more frequent in patients with IDDM (94%), GD (80%), and AD (89%) compared with controls (66%). HLA DQB10201 and DQB10302 were more frequent in IDDM patients (0201, 62% vs. 36% in controls, 0302, 59% vs. 19% controls), whereas DQB10602 was less frequent in IDDM (4%) and GD (18% vs. 31% of controls). In conclusion, endocrine autoimmunity has a common immunogenetic background; susceptibility is conferred by DQA10501 as well as an arginine at position 52 of DQA1 alleles, and protection against IDDM and GD is conferred by DQB1*0602.
由于特定的人类白细胞抗原(HLA)DQ等位基因是1型糖尿病(IDDM)的主要易感因素,我们研究了其他内分泌自身免疫性疾病是否也具有这些等位基因。因此,我们分析了171例IDDM患者、271例格雷夫斯病(GD)患者、65例桥本甲状腺炎患者、51例产后甲状腺炎患者、53例艾迪生病(AD)患者以及271例健康对照者的HLA DQ基因型。通过聚合酶链反应和序列特异性寡核苷酸杂交以及单链构象多态性分析来确定HLA DQA1和DQB1等位基因。HLA DQA10501在IDDM(60%)、GD(65%)和AD(70%)患者中的出现频率显著高于对照组(43%);DQA10301仅在IDDM患者中出现频率显著更高(67%对对照组的30%)。杂合状态DQA1*0301/0501在9%的对照组和35%的IDDM患者中被发现(相对风险为5.6)。与对照组(66%)相比,IDDM患者(94%)、GD患者(80%)和AD患者(89%)中DQA1等位基因第52位为精氨酸的情况更为常见。HLA DQB102